Clinical Trial Update: Evaluation of Efficacy and Safety of THRV-1268 in Long QT Syndrome Type 2 (LQTS 2) [Phase 2, Phase 3]

View source ↗

Summary

This document notes that THRV-1268 is being evaluated in Phase 2/3 trials for Long QT syndrome type 2 and is currently recruiting to assess efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Long Qt Syndrome Type

Drugs mentioned

• Thrv-1268

Snippet

Sponsor: Thryv Therapeutics, Inc. | Conditions: Long QT Syndrome (LQTS) 2 | Phase 2, Phase 3 | Status: RECRUITING